Key facts
- MedaSync’s last known valuation is $11.2M (Aug 2025).
- It has raised $3.6M across 2 recorded rounds; the latest was Seed Round ($1.6M) in Feb 2024.
- Notable investors include Interstate Fusion Ventures, Aztec Capital, Innovation Fund America, Omega Healthcare Investors, Valley Growth Ventures — 6 tracked in total.
- MedaSync has filed 2 Form Ds with the SEC since 2018, most recently Aug 2025 ($1.6M sold to 18 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for MedaSync
Funding rounds
2 roundsAbout MedaSync
Developer of a reimbursement software designed to automate and streamline the operations of skilled nursing operators. The company's software helps in revenue optimization, controlling costs and evaluating historical and real-time data to identify trends and support decision-making, enabling healthcare businesses to provide quality care while maintaining profitability.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2016
- Employees
- 7
- Website
- medasync.com/
- Ownership
- Privately Held (backing)
MedaSync doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedaSync shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedaSync in its N-PORT filings yet. We sweep new filings monthly.